TickerFacts.

Biotricity Inc. (BTCY): Operating Income

Annual figures by period end, from SEC filings.

$1.69M
Year ended 2026-03-31
$1.57M
Trailing 12 months to 2026-06-30
2022-03-31: -$16.74M2023-03-31: -$15.41M2024-03-31: -$8.83M2025-03-31: -$2.45M2026-03-31: $1.69M$1.69M
2022-03-31 Operating Income (USD) 2026-03-31
Period endedOperating IncomeChange YoYSource filing
2026-03-31$1.69Mn/m2026-07-14, From 2025-04-01
2025-03-31-$2.45Mn/m2026-07-14, From 2024-04-01
2024-03-31-$8.83Mn/m2025-07-18, From 2023-04-01
2023-03-31-$15.41Mn/m2024-06-27, From 2022-04-01
2022-03-31-$16.74Mn/a2023-06-29, From 2021-04-01

Operating Income at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedOperating IncomeChange YoY
Biotricity Inc. (BTCY)2026-03-31$1.69Mn/m
Profound Medical Corp. (PROF)2025-12-31-$41.25Mn/m
Allurion Technologies, Inc. (ALUR)2025-12-31-$30.16Mn/m
Vivos Therapeutics, Inc. (VVOS)2025-12-31-$19.89Mn/m
Nephros Inc (NEPH)2025-12-31$1.15Mn/m
Sonoma Pharmaceuticals, Inc. (SNOA)2026-03-31-$2.46Mn/m
Spectral AI, Inc. (MDAI)2025-12-31-$8.60Mn/m
DarioHealth Corp. (DRIO)2025-12-31-$36.66Mn/m
Nexgel, Inc. (NXGL)2025-12-31-$3.35Mn/m

Compare BTCY, PROF, ALUR, VVOS side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗